Mosliciguat

N/A

Report date: 2024/10/11 20:00:59

Base Information

Drug NameMosliciguat
Drug Alias NameBAY-1237592
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsFibrosisVascular DiseasesCardiovascular Diseases +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[5
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFibrosisVascular DiseasesLung Diseases, Interstitial +[5
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A